GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Zoltek Companies Inc. (ZOLT) CFO Andrew W Whipple buys 1,000 Shares

May 18, 2009 | About:
insider

CFO of Zoltek Companies Inc. (ZOLT) Andrew W Whipple buys 1,000 shares of ZOLT on 05/14/2009 at an average price of $7.34 a share.

Zoltek Companies Inc. is an applied technology and advanced materials company. Their primary focus is the manufacturing and marketing of carbon fibers. The most significant current application for carbon fibers produced by Zoltek is for aircraft brake manufacturers who use their fibers as base materials for the carbon/carbon brake systems used in most newly designed aircraft. Zoltek Companies Inc. has a market cap of $276.6 million; its shares were traded at around $8.04 with a P/E ratio of 33.5 and P/S ratio of 1.5.

Recent Trades of Zoltek Companies Inc. by CEO:


  • Buy: Chair. of the Board, Pres.,CEO, 10% Owner Zsolt Rumy bought 25,000 shares of ZOLT stock on 03/13/2009 at the average price of $6.4; the price of the stock has increased by 25.63% since.


Recent Trades of Zoltek Companies Inc. by CFO:


  • Buy: CFO Andrew W Whipple bought 1,000 shares of ZOLT stock on 05/14/2009 at the average price of $7.34; the price of the stock has increased by 9.54% since.


Recent Trades of Zoltek Companies Inc. by Directors and Officers:


  • Buy: Director Charles A Dill bought 10,000 shares of ZOLT stock on 03/13/2009 at the average price of $6.47; the price of the stock has increased by 24.27% since.
  • Buy: Director Michael D Latta bought 29,944 shares of ZOLT stock on 12/11/2008 at the average price of $6.97; the price of the stock has increased by 15.35% since.



Rating: 3.8/5 (4 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK